DexCom is transforming into the premium CGM provider with the lowest cost per patient-day and robust clinical evidence, ...
How big is the sensor patch market, and why is it growing so fast? The global sensor patch market is valued at USD 7.9 ...
10don MSN
Vanderbilt football's Austin Howard isn't letting type 1 diabetes limit him. It's his superpower.
Vanderbilt football linebacker Austin Howard is using his type 1 diabetes diagnosis for good after looking to professional ...
A Type 2 diabetes patient prepares to attach his Dexcom sensor, part of a continuous glucose monitoring system, on his ...
A new methodological perspective uses the Sinocare iCan i3 real-world accuracy study to argue that continuous glucose ...
Verywell Health on MSN
Why CGMs are becoming a wellness trend for your patients
It seems like everyone’s tracking their blood sugar now. Should they be?
Domestic pharmaceutical companies continue to enter the continuous glucose monitoring, CGM, business. As Daewoong ...
ShinyHunters listed O’Reilly Automotive and Dexcom on a new dark web leak site. The group threatened to publish alleged corporate data if the companies did not respond by Friday. O’Reilly runs more ...
Continuous glucose monitoring (CGM) represents one of the most commercially robust sectors within medical technology, ...
DexCom stock (ISIN US2521311074) closed at USD 86.62 on Nasdaq on September 25, 2026, down 0.97 percent from the prior close. The latest quarterly report showed revenue of USD 1.31 billion, up 13.1 ...
Citi reiterated its top picks in the medtech sector, highlighting Abbott Laboratories and Dexcom as standout opportunities while pointing to diverging fortunes across the industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results